September 20, 2012 - (ARM) - The Alliance for Regenerative Medicine (ARM), the advocacy voice for regenerative medicine, has significant concerns about the automatic budget cuts to the US Food and Drug Administration (FDA) and National Institutes of Health (NIH) scheduled to take affect on January 2, 2013 under sequestration provisions of federal law. Read Full Article
